Avastin effective at delaying brain tumor progression in recurrent disease

The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news158247276.html">Avastin effective at delaying brain tumor progression in recurrent disease</a></p> <p>The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance.</p>